AKT1 and gastric cancer: It has been reported that SLC25A5-AS1 functions as a suppressor in the progression of gastric cancer to regulate cellular behaviors via the miR-19a-3p/PTEN/PI3K/AKT signaling pathway (Li et al., 2019).